Vaxil Bio (TSXV:VXL) FFO


TSXV:VXL Vaxil Bio Ltd TSXV:VXL
38 GF Score
Price C$0.18
! 2 Warning Signs
View Full Analysis

What is Vaxil Bio FFO?

FFO (Funds from operations) only applies to REITs.

TSXV:VXL
38GF Score
Vaxil Bio Ltd TSXV:VXL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxil Bio Business Description

Other Exchanges VXLLF:USA
Address 559 Briar Hill Avenue, Toronto, ON, CAN, M5N 1N1
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
38GF Score

Get the complete analysis for TSXV:VXL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.18
Price